Items

• Severe hyperkalemia induced by propranolol (2014)

  D. Mandić, L. Nežić, R. Škrbić, Severe hyperkalemia induced by propranolol, MEDICINSKI PREGLED, Vol. 67, No. 5-6, pp. 181 - 184, 2014

• The Basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots (2014-03)

  M. Donzelli, A. Derungs, L. Nežić, M. Serratore, C. Noppen, S. Krahenbuhel, M. Haschke, The Basel cocktail for simultaneous phenotyping of human cytochrome P450 isoforms in plasma, saliva and dried blood spots, CLINICAL PHARMACOKINETICS, Vol. 53, No. 3, pp. 271 - 282, Mar, 2014

• Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy (2014-07)

  L. Nežić, A. Derungs, M. Bruggisser, S. Tschudin-Sutter, S. Krahenbuhel, M. Haschke, Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, Vol. 70, No. 7, pp. 829 - 837, Jul, 2014

• Treatment of recurrent aphthous stomatitis by laser therapy: A systematic review of the literature (2015-08)

  V. Pavlić, V. Vujić-Aleksić, A. Aoki, L. Nežić, Treatment of recurrent aphthous stomatitis by laser therapy: A systematic review of the literature, VOJNOSANITETSKI PREGLED, Vol. 8, No. 72, pp. 722 - 728, Aug, 2015

• Drug Induced Liver Injury: Pathogenesis, Clinical Features and Monitoring (2016-10)

  A. Ćurguz, L. Nežić, D. Mandić, Drug Induced Liver Injury: Pathogenesis, Clinical Features and Monitoring, SCRIPTA MEDICA, Vol. 47, No. 2, pp. 140 - 147, Oct, 2016

• Neodgovarajuće propisivanje lijekova starijim osobama u primarnoj zdravstvenoj zaštiti (2016-12)

  N. Jotanovic, L. Nežić, M. Vučen, D. Lakić, B. Đukić, D. Mandić, Neodgovarajuće propisivanje lijekova starijim osobama u primarnoj zdravstvenoj zaštiti, BIOMEDICINSKA ISTRAŽIVANjA, Vol. 7, No. 2, pp. 168 - 177, Dec, 2016

• Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225 (2018-04)

  I. Andreadou, P. Adamovski, M. Bartekova, C. Beauloye, L. Bertrand, D. Biedermann, V. Borutaite, H. Erik Botker, M. Dambrova, S. Chlopicki, Y. Devaux, S. Davidson, F. Di Lisa, D. Djuric, D. Erlinge, I. Falcao-Pires, E. Galatou, D. Garcia-Dorado, A. Garcia-Sosa, H. Girao, M. Gyongyosi, Z. Giricz, D. Healy, G. Heusch, V. Jakovljevic, J. Jovanic, F. Kolar, B. Kwak, P. Leszek, E. Liepnish, S. Longnus, J. Marinovic, D. Muntean, L. Nežić, M. Ovize, P. Paglliaro, C. Pedrosa da Costa Gomes, J. Pernow, A. Persidis, S. Pischke, B. Podesser, F. Prunier, T. Ravingerova, M. Ruiz-Meana, R. Schulz, A. Scridon, K. Slagsvold, J. Lonborg, B. Turan, N. van Royen, M. Vendelin, S. Walsh, D. Yellon, N. Zidar, C. Zuurbier, P. Ferdinandy, D. Hausenloy, Realizing the therapeutic potential of novel cardioprotective therapies: The EU-CARDIOPROTECTION COST Action - CA16225, Conditioning medicine, Vol. 1, No. 3, pp. 116 - 123, Apr, 2018

• Clinical Trials and the Importance of Biobanks in Rare diseases (2019-03)

  L.Nežić, V. Vujuć-Aleksić, M. Dukić, A. Đeri, Clinical Trials and the Importance of Biobanks in Rare diseases, SCRIPTA MEDICA, Vol. 49, No. 1, pp. 49 - 56, Mar, 2019

• Mandibular bone loss in experimetal osteoporosis and efficacy of antiresorptive treatment (2007)

  A. Đeri, L. Nežić, L. Latinović Tadić, Mandibular bone loss in experimetal osteoporosis and efficacy of antiresorptive treatment, Abstract Book, 2007

• Quality of Drug Prescribing Among Elderly Residents in Nursing Home (2008)

  L. Nežić, D. Mandić, Quality of Drug Prescribing Among Elderly Residents in Nursing Home, Abstract book, 2008

• Potenital drug drug interaction in the treatment of elderly patients in family medicine practice (2009)

  L. Nežić, D. Mandić, N. Broćeta Pilipović, Potenital drug drug interaction in the treatment of elderly patients in family medicine practice, Abstract book, 2009

• Pharmacokinetic profile of efavirenz in dried blood spot (DBS) samples. Comparison of manual sample preparation and automated on-line extraction with the CAMAG DBS-MS device (2010)

  M. Donzelli, L. Nežić, S. Krahenbuhel, Pharmacokinetic profile of efavirenz in dried blood spot (DBS) samples. Comparison of manual sample preparation and automated on-line extraction with the CAMAG DBS-MS device, Abstract book, 2010

• TDM once-daily aminoglycoside dosing: usefulness of alorithm to estimate Cmax and AUC (2011)

  M. Bruggisser, L. Nežić, M. Donzelli, S. Krahenbuhel, M. Haschke, TDM once-daily aminoglycoside dosing: usefulness of alorithm to estimate Cmax and AUC, Abstract book, 2011

• New applications for an old technique: Clinical Validation of Dried Blood Spot (DBS) sampling for CYP1A2 phenotyping (2011-04)

  M. Donzelli, S. Krahenbuhel, L. Nežić, New applications for an old technique: Clinical Validation of Dried Blood Spot (DBS) sampling for CYP1A2 phenotyping, Abstract book, Apr, 2011

• Potentially inappropriate medications in elderly nursing home residents with cardiovascular diseases (2016)

  D. Mandić, L. Nežić, R. Škrbić, Potentially inappropriate medications in elderly nursing home residents with cardiovascular diseases, 2016

• Amelioration of lipopolysaccharide-induced acute kidney injury by simvastatin: involvement of mitochondrial apoptotic and NF-kB signalling pathways (2018)

  L. Nežić, L. Amidzic, R. Škrbić, Amelioration of lipopolysaccharide-induced acute kidney injury by simvastatin: involvement of mitochondrial apoptotic and NF-kB signalling pathways, 2018

• Simvastatin protects against endotoxin induced acute lung injury and apopto- sis via activation of survivin/NF-kB signaling pathway (2018)

  L. Nežić, R. Škrbić, L. Amidzic, Simvastatin protects against endotoxin induced acute lung injury and apopto- sis via activation of survivin/NF-kB signaling pathway, Abstract book, 2018

• Svijest i stavovi ljekara o upotrebi biološli sličnih lijekova: pilot studija u Republici Srpskoj (2019-09)

  N. Stojaković, V. Gužvić, A. J. Golić, S. Stoisavljević-Šatara, R. Škrbić, L. Nežić, Svijest i stavovi ljekara o upotrebi biološli sličnih lijekova: pilot studija u Republici Srpskoj, Sep, 2019

• Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings (2023-10)

  B. Mirjanić-Azarić, S. Stanković, L. Nežić, Ž. Radić, D. Malčić Zanić, R. Škrbić, J. Kotur -Stevuljević, N. Bogavac-Stanojević, Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings, Front Oncol ., Vol. 13, pp. 1221414. - 1221414., Oct, 2023

• Žučne kiseline kao novi terapijski agensi. U:Spomenica Boriše Starovića izdanje 2006. godine SPOMENICA Knj. IV. Odjeljenje medicinskih nauka Knjiga 1 (2006)

  N. Stojaković, R. Škrbić, S. Stoisavljević-Šatara, L. Nežić, Žučne kiseline kao novi terapijski agensi. U:Spomenica Boriše Starovića izdanje 2006. godine SPOMENICA Knj. IV. Odjeljenje medicinskih nauka Knjiga 1, Akademija nauka i umjetnosti Republike Srpske, Banja Luka, Republika Srpska, Bosna i Hercegovina, 2006